Synmosa Biopharma Market Cap

Synmosa Biopharma has a market cap or net worth of 16.32 billion as of June 27, 2025. Its market cap has increased by 6.80% in one year.

Market Cap

16.32B

Enterprise Value

16.98B

Revenue

5.72B

Ranking

n/a

PE Ratio

21.44

Stock Price

36.55

Market Cap Chart

Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 16.32B, an increase of 2,697.15%. That is a compound annual growth rate of 19.00%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	16.64B	14.77%
Dec 31, 2024	14.50B	-1.41%
Dec 29, 2023	14.71B	-8.20%
Dec 30, 2022	16.02B	128.36%
Dec 30, 2021	7.02B	2.96%
Dec 31, 2020	6.81B	20.87%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	190.00B
PharmaEssentia	181.63B
Bora Pharmaceuticals Co., LTD.	84.20B
Lotus Pharmaceutical	57.58B
Oneness Biotech	31.37B
Polaris Group	29.47B
Center Laboratories	27.35B
Lumosa Therapeutics	25.66B

Market Cap Rankings